Indivior (LON:INDV) Stock Price Down 17% – Should You Sell?

Shares of Indivior PLC (LON:INDV) traded down 17% on Thursday . The stock traded as low as GBX 548.71 ($6.93) and last traded at GBX 720.60 ($9.10). 2,904,792 shares were traded during mid-day trading, an increase of 294% from the average session volume of 737,710 shares. The stock had previously closed at GBX 868 ($10.97).

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group reaffirmed a “buy” rating and set a GBX 1,800 ($22.74) price target on shares of Indivior in a research note on Tuesday, December 17th.

Indivior Trading Down 5.9 %

The business has a 50 day moving average of GBX 920.11 and a 200 day moving average of GBX 850.81. The company has a debt-to-equity ratio of -170.06, a current ratio of 0.83 and a quick ratio of 1.52. The firm has a market capitalization of £1.08 billion, a price-to-earnings ratio of -570.87, a PEG ratio of -5.57 and a beta of 0.19.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.